These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9531920)

  • 1. [Irbesartan--current trends in the management of hypertension].
    Dtsch Med Wochenschr; 1998 Feb; 123(8 Suppl):1-4. PubMed ID: 9531920
    [No Abstract]   [Full Text] [Related]  

  • 2. Irbesartan for hypertension.
    Med Lett Drugs Ther; 1998 Jan; 40(1019):18-9. PubMed ID: 9465857
    [No Abstract]   [Full Text] [Related]  

  • 3. Irbesartan achieves consistent and effective use over 1 year.
    Cardiovasc J S Afr; 2001; 12(2):126. PubMed ID: 11474701
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enalapril and irbesartan in treatment of patients with arterial hypertension].
    Tashchuk VK; Ilashchuk TO
    Lik Sprava; 2002; (3-4):114-6. PubMed ID: 12145874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irbesartan slows the development of diabetic nephropathy by up to 70% in hypertensive diabetic patients.
    Cardiovasc J S Afr; 2001; 12(4):242-3. PubMed ID: 11766619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health economic aspects of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
    Schute LL
    Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1448; author reply 1448. PubMed ID: 15213879
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
    Liberopoulos E; Christides D; Elisaf M
    J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
    [No Abstract]   [Full Text] [Related]  

  • 8. EC approves irbesartan for the treatment of diabetic renal disease.
    Cardiovasc J S Afr; 2002; 13(4):216-7. PubMed ID: 12402931
    [No Abstract]   [Full Text] [Related]  

  • 9. Irbesartan treatment in hypertension.
    Brown MJ
    Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache, hypertension, and irbesartan therapy.
    Benseñor IM; Lotufo PA
    Arch Intern Med; 2001 Mar; 161(5):775-6. PubMed ID: 11231724
    [No Abstract]   [Full Text] [Related]  

  • 11. Irbesartan prevents the progression of kidney disease or death in patients with type 2 diabetes and high blood pressure.
    Cardiovasc J S Afr; 2001; 12(4):240-1. PubMed ID: 11766617
    [No Abstract]   [Full Text] [Related]  

  • 12. Problems with interpreting the data in Kassler-Taub et al's article comparing irbesartan and losartan.
    Bunt T
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):79-81. PubMed ID: 10075390
    [No Abstract]   [Full Text] [Related]  

  • 13. Losartan--a new antihypertensive.
    Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
    [No Abstract]   [Full Text] [Related]  

  • 14. A look through the new therapeutic window: irbesartan.
    Waeber B; Brunner HR
    J Hypertens Suppl; 1998 Sep; 16(7):S11-6. PubMed ID: 9855026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical overview of irbesartan: expanding the therapeutic window in hypertension.
    Man in't Veld AJ
    J Hypertens Suppl; 1997 Dec; 15(7):S27-33. PubMed ID: 9532518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focus on compliance. Rapid goal attainment in hypertension].
    Riem L
    MMW Fortschr Med; 2011 Jan; 153(4):51. PubMed ID: 22165621
    [No Abstract]   [Full Text] [Related]  

  • 17. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug interactions with irbesartan.
    Marino MR; Vachharajani NN
    Clin Pharmacokinet; 2001; 40(8):605-14. PubMed ID: 11523726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective.
    Kurland L
    Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EFFECTIVE data. New effectiveness dimensions in antihypertensive combination therapy].
    MMW Fortschr Med; 2011 Jan; 153(4):50. PubMed ID: 22165620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.